Loading
Latest filing published 24 May 2017 for Tetra Bio-Pharma Inc., €3,240.
No signal scores available.
Denis Courchesne is a declared insider of Tetra Bio-Pharma Inc., with filings sourced from SEDI. Over a trading history stretching from 4 May 2017 to 18 May 2017, the count stands at 2 filings.
No open-market sale appears; the market trades are 1 purchase worth €3,240. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 24 May 2017, the filings show an open-market purchase worth €3,240 in Tetra Bio-Pharma Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations